| 000147 (2001) |
| Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases. |
| 000168 (1999) |
| Factor analysis of dynamic series (FADS) in somatostatin receptor imaging. |
| 000172 (1999) |
| Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. |
| 000175 (1998) |
| Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. |
| 000180 (1998) |
| In vivo inaccessibility of somatostatin receptors to 111In-pentreotide in primary renal cell carcinoma. |
| 000227 (1994) |
| Scintiscans and carcinoid tumors. |
| 000266 (1991) |
| Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients. |
| 000282 (1990) |
| Imaging of inflammatory bowel disease (IBD) and scintigraphic assessment of resected colon: comparison of 111 In-oxine and 99mTC HMPAO leucocyte labelling. |
| 000058 (2009) |
| Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study. |
| 000060 (2009) |
| Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors. |
| 000075 (2008) |
| Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy. |
| 000076 (2008) |
| Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors. |
| 000110 (2005) |
| Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. |
| 000125 (2004) |
| Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans. |
| 000132 (2003) |
| Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects. |
| 000134 (2003) |
| Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck. |
| 000135 (2002) |
| [Scintigraphy by l'Octreoscan in the management of head and neck paragangliomas]. |
| 000146 (2001) |
| Is the thrombopoietin assay useful for differential diagnosis of thrombocytopenia? Analysis of a cohort of 160 patients with thrombocytopenia and defined platelet life span. |
| 000154 (2000) |
| Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography. |
| 000163 (1999) |
| Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo. |
| 000170 (1999) |
| Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy. |
| 000174 (1999) |
| 111Indium antimyosin antibody imaging of primary myocardial involvement in systemic diseases. |
| 000176 (1998) |
| Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. |
| 000197 (1996) |
| Somatostatin receptor imaging in small cell lung cancer. |
| 000199 (1996) |
| Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. |
| 000207 (1996) |
| Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. |
| 000211 (1995) |
| Somatostatin receptor imaging: a preliminary experience in forty-nine patients. |
| 000221 (1995) |
| Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. |
| 000237 (1993) |
| Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay. |
| 000239 (1993) |
| Splenectomy in idiopathic thrombocytopenic purpura: its correlation with the sequestration of autologous indium-111-labeled platelets. |
| 000248 (1993) |
| Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. |
| 000260 (1992) |
| Bronchial clearance of DTPA is increased in acute asthma but not in chronic asthma. |
| 000289 (1989) |
| Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies. |
| 000298 (1988) |
| Indium-111 platelet scintigraphy in carotid disease. |
| 000023 (2012) |
| Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement. |
| 000084 (2007) |
| Pathology underrates colon cancer extranodal and nodal metastases; ex vivo radioimmunodetection helps staging. |
| 000094 (2006) |
| Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. |
| 000102 (2006) |
| Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. |
| 000129 (2003) |
| Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial. |
| 000144 (2001) |
| Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. |
| 000149 (2001) |
| Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy. |
| 000158 (2000) |
| 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis. |
| 000190 (1997) |
| Indium-111 antimyosin scintigraphy before and after coronary bypass surgery: unexpected preoperative myocardial uptakes. |
| 000210 (1995) |
| [Indium III monoclonal antimyosin antibody scintigraphy for the detection of chronic myocardial infarction apart from the acute phase]. |
| 000225 (1994) |
| Somatostatin receptor imaging in non-functioning pituitary adenomas: value of an uptake index. |
| 000236 (1993) |
| What factors determine indium-111 antimyosin monoclonal antibody uptake in patients with myocardial infarction? |
| 000263 (1991) |
| The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy. |
| 000267 (1991) |
| Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects. |
| 000273 (1991) |
| Diagnosis of left atrial thrombi in mitral stenosis--usefulness of ultrasound techniques compared with other methods. |
| 000280 (1990) |
| Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA. |
| 000286 (1989) |
| Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma. |
| 000292 (1989) |
| Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas. |
| 000318 (????) |
| Contribution of scintigraphy to verify the reliability of different preparation processes for enteric coated capsules. |
| 000100 (2006) |
| Low-dose lactulose produces a tonic contraction in the human colon. |
| 000114 (2005) |
| Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas. |
| 000140 (2002) |
| Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy. |
| 000142 (2001) |
| Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. |
| 000162 (1999) |
| Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy. |
| 000169 (1999) |
| Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. |
| 000183 (1997) |
| [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center]. |
| 000188 (1997) |
| The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. |
| 000193 (1997) |
| Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. |
| 000201 (1996) |
| Labeled granulocyte scanning for the diagnosis of infected necrosis in acute pancreatitis: what kind of labeling should be used? |
| 000206 (1996) |
| Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours. |
| 000217 (1995) |
| Indium-111 pentetreotide scintigraphy in malignant lymphomas. |
| 000224 (1994) |
| Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison. |
| 000228 (1994) |
| Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate. |
| 000229 (1994) |
| Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients. |
| 000235 (1993) |
| [Bone marrow scintigraphy. Contribution to the diagnosis and the prognosis of myelofibrosis]. |
| 000241 (1993) |
| Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. |
| 000258 (1992) |
| Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma. |
| 000268 (1991) |
| Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis. |
| 000269 (1991) |
| Imaging of myocardial infarction in dogs and humans using monoclonal antibodies specific for human myosin heavy chains. |
| 000279 (1990) |
| Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments. |
| 000284 (1990) |
| Detection of prosthetic valve thrombosis using 111indium platelet imaging. |
| 000295 (1988) |
| [Development of left intraventricular thrombi. Monitoring by two-dimensional echocardiography and scintigraphy with indium 111-labelled platelets]. |
| 000300 (1988) |
| Comparison of two-dimensional echocardiography with scanography and indium-111 platelet scintigraphy in detection of intracardiac thrombi. |
| 000323 (????) |
| Acute diffuse myocyte necrosis evidenced with 111In-antimyosin antibody scintigraphy in a patient with aortic stenosis. |
| 000085 (2007) |
| Paraneoplastic ACTH secretion: bronchial carcinoid overlooked by planar indium-111 pentetreotide scintigraphy and accurately localized by SPECT/CT acquisition. |
| 000106 (2006) |
| Bone metastases from head and neck paragangliomas: uncommon MR findings in an uncommon condition--report of three cases. |
| 000111 (2005) |
| Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study. |
| 000141 (2001) |
| [Radio-guided resection of residual metastatic lymph node from a previously resected neuroendocrine tumor]. |
| 000161 (1999) |
| Subarachnoid-pleural fistula complicating thoracoscopy: value of In-111 DTPA myeloscintigraphy. |
| 000165 (1999) |
| In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumors. |
| 000167 (1999) |
| False-positive antimyosin imaging caused by cardioversion-induced skeletal muscle uptake. |
| 000178 (1998) |
| Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. |
| 000184 (1997) |
| Utility of indium-111-antimyosin scintigraphy for diagnosis of myocardial damage in systemic sclerosis. |
| 000191 (1997) |
| False-positive somatostatin receptor scintigraphy due to an accessory spleen. |
| 000192 (1997) |
| Effects of preoperative intentional hemodilution on the extravasation rate of albumin and fluid. |
| 000195 (1996) |
| Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor. |
| 000198 (1996) |
| Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody. |
| 000200 (1996) |
| Left ventricular myocardial uptake of a labeled somatostatin analog in carcinoid syndrome. |
| 000202 (1996) |
| Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors. |
| 000203 (1996) |
| Functional upregulation of granulocytes labeled with technetium-99m-HMPAO and indium-111-oxinate. |
| 000212 (1995) |
| Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer? |
| 000213 (1995) |
| Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma. |
| 000214 (1995) |
| Per operative localization of a carcinoid tumour of the breast using indium-111 pentetreotide and a nuclear surgical probe. |
| 000242 (1993) |
| Platelet production in idiopathic thrombocytopenic purpura. |
| 000243 (1993) |
| New application of myocardial antimyosin scintigraphy: diagnosis of myocardial disease in polymyositis. |
| 000247 (1993) |
| Bone marrow scintigraphy in myelofibrosis. |
